Joel Gelfand, MD, MSCE, on How Does Psoriasis Affect CVD Risk?

 

 

 

Joel M. Gelfand, MD, MSCE, is Director of the Psoriasis and Phototherapy Treatment Center, Vice Chair of Clinical Research and Medical Director of the Dermatology Clinical Studies Unit, Professor of Epidemiology in Biostatistics and Epidemiology, and Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania.

 

RELATED READING
Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality? — Journal of the American Academy of Dermatology

Submit Feedback

Name